Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers

Part of paid clinical trials in Rochester, Minnesota.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT05205343
Status
Recruiting

Conditions

  • Gastric
  • GastroEsophageal Cancer
  • Gastrostomy

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Standard of Care — OTHER
    complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery
  • Control Group — OTHER
    complete a questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery

Study Details

To compare the symptoms of patients who have a MIPG to the symptoms of patients who have a MITG.

Key Dates

Start date
May 11, 2022
Status verified
Feb 2026
Primary completion
May 31, 2026
Completion
May 31, 2026

Study Design

Enrollment
20 participants (estimated)

Arms

  • Arm: Standard of Care
    questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery. The questionnaire will ask about your health, appetite, and quality of life. It should take about 3-5 minutes to complete.
  • Arm: Control group
    questionnaire within 30 days before your surgery and then at 1, 3, 6, and 12 months after surgery. The questionnaire will ask about your health, appetite, and quality of life. It should take about 3-5 minutes to complete.

Primary Outcome Measure

(MDASI-GI) MD Anderson Symptom Inventory Questionnaire [ Time Frame: 3 months after surgery ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Mayo Clinic in RochesterRochesterMinnesota55905-
M D Anderson Cancer CenterHoustonTexas77030
Naruhiko Ikoma, MD
832-729-2675
Naruhiko Ikoma, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Rochester, MN

Related Studies